Optimized heart failure therapy and complete anemia correction on left-ventricular hypertrophy in nondiabetic and diabetic patients undergoing hemodialysis

Kidney and Blood Pressure Research

Volumn 28, Issue 5-6, 2006, Pages 353-362

  Hampl, Hannelore ^a,e   Hennig, Lars ^b   Rosenberger, Christian ^a   Gogoll, Lutz ^b   Riedel, Eberhard ^c   Scherhag, Armin ^d  

^a Renal Centre   (Germany)

^b Institute for Cardiology   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e Renal Centre   (Germany)

Author keywords

Anemia management; Diabetes mellitus; Heart insufficiency therapy; Hemodialysis; Left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERROUS GLUCONATE; HEMOGLOBIN; METOPROLOL; RAMIPRIL; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

ACID-BASE EQUILIBRIUM; AGED; ANEMIA; BLOOD PRESSURE; BODY MASS INDEX; DIABETIC NEPHROPATHIES; ENDPOINT DETERMINATION; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RENAL DIALYSIS; SURVIVAL RATE;

EID: 33644968476     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090190     Document Type: Article

References (23)

1. Bell DSH: Editorials diabetes mellitus. Diabetes Care 2003;26:2941-2951.
2. Palmieri V, Tracy RP, Roman MJ, Liu JE, Bast LG, Bella JN, Robbins DC, Howard BY, Devereux RB, et al: Strong Heart Study: relation of left ventricular hypertrophy, inflammation and albuminuria in adults with type 2 diabetes. Diabetes Care 2003;26:2764-2769.
3. Metzler B, Schocke MF, Steinboeck P, Wolf C, Judmaier W, Lechleitner M, Lukas P, Pachinger O: Decreased high energy phosphate ratios in the myocardium of men with diabetes mellitus type 1. J Cardiovasc Magn Reson 2002;4:493-502.
4. Preik M, Kelm M, Rösen P, Tschöpe D, Strauer BE: Additive effect of coexistent type 2 diabetes and arterial hypertension on endothelial dysfunction in resistance arteries of human forearm vasculature. Angiology 2000;51:545-554.
5. Sowers JR, Epstein M, Fröhlich ED: Diabetes, hypertension and cardiovascular disease. Hypertension 2001;37:1053-1059.
6. Ritz E, Lippert J, Keller G: Rapider Anstieg der Zahl niereninsuffizienter Typ II-Diabetiker. Dtsch Med Wochenschr 1996;121:1244.
7. Sahin DJ, Demaria A, Kisslo J, Weymann A: The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiographic measurements. Circulation 1978;58:1072-1083.
8. Harnett DJ, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995;47:884-890.
9. Hampl H, Hennig L, Rosenberger Ch, Amirkhalili M, Gogoll L, Riedel E, Scherhag A: Effects of optimized heart failure therapy and anemia correction with epoetin β on left ventricular mass in hemodialysis patients. Am J Nephrol 2005;25:211-220.
10. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(suppl 3):112-119.
11. Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC: Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis 2003;41:1267-1277.
12. Schreiber BD: Congestive heart failure in patients with chronic kidney disease and on dialysis. Am J Med Sci 2003;325:179-193.
13. Bosnan DR, Osborn CA, Marsden JT, Macdougall IC, Gardner WN, Watkins PJ: Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Diabet Med 2002;19:65-69.
14. Ludat K, Paulitschke M, Riedel E, Hampl H: Full correction of renal anemia by recombinant human erythropoietin. Clin Nephrol 2000;53(suppl 1):42-49.
15. Amann K, Buzello M, Simonaviciene A, Miltenberger-Miltenyi G, Koch A, Nabokov A, Gross ML, Gless B, Mall G, Ritz E: Capillary/Myocyte-mismatch in the heart in renal failure: a role for epoetin? Nephrol Dial Transplant 2000;15:964-969.
16. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal versus low treated hematocrit values in hemodialysis patients with cardiac disease with erythropoietin. N Engl J Med 1998;339:584-590.
17. Herzog CA, Ma JZ, Collins AJ: Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:799-805.
18. Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Augustin W, Kraemer K, Hampl H, Sommerburg O: Oxidative stress in cardio-renal anemia syndrome: Correlations and therapeutic possibilities. Clin Nephrol 2003;60(suppl 1):22-30.
19. Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Augustin W, Hampl H, Riehle M, Sommerburg O: Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol 2002;58(suppl 1):12-19.
20. Nickenig G, Böhm M: Interaction between insulin and AT1-receptor. Relevance for hypertension and arteriosclerosis. Basic Res Cardiol 1998;93(suppl 2):135-139.
21. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, SCOPE Study Group: The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention study. J Hypertens 2003;21:875-886.
22. Raml A, Janko O, Biesenbach G: Verkürzte Lebenserwartung bei dialysepflichtigen Typ 2-Diabetikern mit peripherer arterieller Verschlusskrankheit bei Beginn der Dialysetherapie. Nieren Hochdruckkr 2004;33:369-394.
23. Wanner Ch, Krane V, März W, Olschewski M, Asmus HG, Krämer W, Kühn KW, Kütemeyer H, Mann JH, Ruf G, Ritz E, Deutsche Diabetes-Dialyse-Studie (4D): Randomized controlled study on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res 2004;27:259-266.